Featured Article
Academic Journal
Main Category: MRSA / Drug Resistance
  Also Included In: Nutrition / Diet;  Genetics
  Article Date: 28 Aug 2012 – 2:00 PDT  
email to a friend printer friendly opinions
<!– rate article
Patient / Public:
Healthcare Prof:
4 (1 votes)
Nicotinamide, commonly known as vitamin B3, may help the innate immune system kill antibiotic-resistant staph bacteria, the so-called “superbugs”.
  In lab work done with mice and human blood, researchers found high doses of the vitamin increased the ability of immune cells to kill the bacteria by 1,000
  times.  
  The discovery opens the door to a new arsenal of tools for dealing with antibiotic-resistant bacterial infections, such as those caused by methicillin-resistant
  S. aureus or MRSA, that have killed thousands of people around the world. They are increasing in hospitals and nursing homes, and also rising in
  prisons, among athletes, people in the military, and other places where many people are in close and frequent contact.
  The team members behind the work are from Cedars-Sinai Medical Center, the Linus Pauling Institute at Oregon State University (OSU), the University of
  California Los Angeles (UCLA), and other research centers.  They write about it in a paper published online this week in the Journal of Clinical
  Investigation.  
Potential for Use with Antibiotics
Co-author Adrian Gombart is an associate professor in the Linus Pauling Institute at OSU.  He told the press the study could be very significant, but the results
  have to be replicated in humans first:  
“This could give us a new way to treat staph infections that can be deadly, and might be used in combination with current antibiotics,” said Gombart.
  “It’s a way to tap into the power of the innate immune system and stimulate it to provide a more powerful and natural immune response,” he
  added.
  Although antibiotics are very effective against bacterial infections, an increasing number of bacteria types, especially  Staphylococcus aureus, are
  becoming resistant to them, leaving fewer and fewer options for treatment.
  Some believe the widespread use of antibiotics, coupled with mismanagement of their doses, creates an evolutionary pressure that helps increase the emergence
  and spread of resistant strains.
One of the most common of these is MRSA, which the investigators included in this study.
Gene Mutation Causes Vulnerability to Bacterial Infection
A decade ago, Gombart discovered that a mutation of the C/EBPε gene  in humans makes some people more vulnerable to bacterial infection.  Working on
  this problem led to finding that nicotinamide can “switch on” some of the disabled anti-microbial genes, giving immune cells greater capacity to kill
  infectious bacteria.  
The authors summarize this in their abstract:
  “The myeloid-specific transcription factor, CCAAT/enhancer-binding protein ε (C/EBPε) is a critical mediator of myelopoiesis. Mutation of this gene is responsible
  for neutrophil-specific granule deficiency in humans, a condition that confers susceptibility to Staphylococcus aureus infection.”  
The Study
In this latest study, the team showed mice bred to be deficient in C/EBPε were severely affected by infection with  S. aureus, and it was deficiency of the
   C/EBPε protein in their neutrophils (a type of white blood cell that kills and devours harmful bacteria), that was responsible.  
  They then showed that high doses of vitamin B3 (the molecule acts as an “epigenetic modulator”, that is it can switch genes on an off) increasing expression of
  C/EBPε in cultures of the appropriate (myeloid) immune cells.
In another experiment, they also found that vitamin B3 increased the activity of the gene, and selected bacterial targets, particularly in neutrophils.
  And finally, in a mouse model, as well as in mouse and human blood cultures, they showed vitamin B3 “enhanced killing of S. aureus by up to 1,000
  fold”, but it had no effect when given to mice that were either deficient in C/EBPε or in mice depleted of neutrophils.
The researchers found that in human blood, vitamin B3 was able to wipe out the staph infection in a few hours.
Implications
“Our findings suggest that C/EBPε is an important target to boost killing of bacteria by the innate immune system,” conclude the authors.
Co-senior author George Liu, an infectious disease expert at Cedars-Sinai, said:
“This vitamin is surprisingly effective in fighting off and protecting against one of today’s most concerning public health threats.”
Approaches like this could help reduce dependence on antibiotics, he added.
  The doses used in the study were megadoses, at therapeutic levels, which are much much bigger than the amount of vitamin B3 in a normal diet.  However, such
  levels have been used safely in humans for other medical reasons.
  But this fact, together with the findings of this study, are not sufficient reason for people to start medicating themselves with high doses of vitamin
  B3.
Several grants from the National Institutes of Health helped pay for the study.
Written by Catharine Paddock PhD
Copyright: Medical News Today
  
Not to be reproduced without permission of Medical News Today
  
- Additional
 - References
 - Citations
 
“C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice”; Pierre Kyme, Nils H. Thoennissen, Ching Wen Tseng,
Gabriela B. Thoennissen, Andrea J. Wolf, Kenichi Shimada, Utz O. Krug, Kunik Lee, Carsten Müller-Tidow, Wolfgang E. Berdel, W. David Hardy, Adrian F.
Gombart, H. Phillip Koeffler, George Y. Liu; J Clin Invest, published online 27 August 2012; DOI:10.1172/JCI62070; Link to Article.
Additional source: Oregon State University.
Please use one of the following formats to cite this article in your essay, paper or report:
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
‘Vitamin B3 May Help Kill Superbugs’
Please note that we publish your name, but we do not publish your email address. It is only used to let
  	  you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
  Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
  professional. For more information, please read our terms and conditions.  
  Privacy Policy |
  Terms and Conditions  
  MediLexicon International Ltd
  Bexhill-on-Sea, United Kingdom
  MediLexicon International Ltd © 2004-2012 All rights reserved.
  MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.  
back to top | home |
  privacy policy
MediLexicon International Ltd
  Bexhill-on-Sea, United Kingdom
  MediLexicon International Ltd © 2004-2012 All rights reserved.
  MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
No comments:
Post a Comment